"...ATryn trials test individuals with HD who undergo elective surgery or childbirth."
Huh ?
Well, if so, will the approved indication that they are seeking be confined to this class of individuals ? And if so, why so narrow a class ? (almost a "sub-group" !?)
"....on the biotech battle-field, you need some élan...."